Unstable Angina Therapeutics - Pipeline Assessment and Market Forecast to 2018 
MarketWatch (press release)
Summary GlobalData, the industry analysis specialist, has released its new report, "Unstable Angina Therapeutics - Pipeline Assessment and Market Forecast to 2018". The report is an essential source of information and analysis on the global Unstable ...
New Market Study: "Unstable Angina Therapeutics - Pipeline Assessment and ... SBWire (press release)

all 7 news articles » 

ARK THERAPEUTICS GROUP PLC Completion of the dose ranging Phase I section of ... 
PharmaLive.com (press release)
London, UK, 16 May 2012 - Ark Therapeutics Group plc (AKT: LSE) ("Ark" or "the Company") is pleased to announce completion of the dose ranging Phase I section of the academic study of Ark's VEGF-D adenoviral vector treatment for refractory angina.

and more » 

Charities in cardiac rehab demand 
Fife Today
They want more angina sufferers and people with heart failure to be able to benefit from the treatment. The British Heart Foundation (BHF) Scotland and Chest, Heart and Stroke Scotland (CHSS) said that while almost two thirds of those who have had ...
Cardiac rehabilitation appeal made The Press Association
Call for more heart patients to be offered cardiac rehab Scotsman

all 121 news articles » 

New Market Study: "Unstable Angina Therapeutics - Pipeline Assessment and ... 
SBWire (press release)
Williamstown, MA -- (SBWIRE) -- 05/10/2012 -- GlobalData, the industry analysis specialist, has released its new report, "Unstable Angina Therapeutics - Pipeline Assessment and Market Forecast to 2018". The report is an essential source of information ...

and more » 

Worthing Hospital heart lab needs fund-raising support 
Worthing Herald
?Fortunately, my wife encouraged me to make an appointment with my GP when we returned home and I was diagnosed with angina.? Angina is caused by lack of blood supply due to a narrowing of the coronary arteries. The diagnosis was the start of a process ...

and more » 

Unstable Angina Therapeutics - Pipeline Assessment and Market Forecast to 2018 
DigitalJournal.com (press release)
GlobalData, the industry analysis specialist, has released its new report, "Unstable Angina Therapeutics - Pipeline Assessment and Market Forecast to 2018". The report is an essential source of information and analysis on the global Unstable Angina ...

and more » 

Post-PCI Bleeds Drop with Shifts in Drug Strategy 
MedPage Today
According to previous research, among patients with elective PCI, unstable angina/non-ST-segment elevation myocardial infarction (NSTEMI), and STEMI, there was a "a modest but significant decrease" in post-PCI bleeding from 2005 to 2009 (2.49% to ...

 

Cardium Reports New Catheter-Based Methods Significantly Boost Cardiac Gene ... 
MarketWatch (press release)
Generx (Ad5FGF-4) is a disease-modifying regenerative medicine biologic that is being developed to offer a one-time, non-surgical option for the treatment of myocardial ischemia in patients with stable angina due to coronary artery disease, ...
Delivery of gene-therapy for heart disease boosted 100-fold; now in 100 ... Science Codex

all 7 news articles » 

WELLNESS WEDNESDAY: Getting active could be the new 'wonder drug' 
Muncie Star Press
Overweight and obese people have an increased rate of heart disease, heart attack, congestive heart failure, sudden cardiac death, angina and abnormal heart rhythm more often than those who maintain a healthy body mass index. In 1985, not one state had ...

and more » 

FAME II: Should Fractional Flow Reserve (FFR) Be Mandatory? 
Angioplasty.Org
I wrote about FAME II back in January, when enrollment in the trial was halted for ethical reasons because the results of the ongoing FAME II trial were showing that the outcomes for stents in patients with stable angina were clearly superior to those ...
FAME II: FFR pinpoints stable CAD patients who fare worse with OMT TheHeart.Org

all 21 news articles »